Source:http://linkedlifedata.com/resource/pubmed/id/20375073
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2010-6-30
|
pubmed:abstractText |
E-cadherin, as a tumor suppressor, plays an important role for intercellular adhesion involved in metastasis. Although K-Ras is highly expressed in a variety of cancers, the regulation of E-cadherin expression by K-Ras in association with DNA methylation and cell metastasis has not been completely clarified. In this study, E-cadherin expression was repressed in 267B1/K-Ras human epithelial prostate cancer cells stably overexpressing K-Ras, resulting from hypermethylation of E-cadherin promoter as evidenced by methylation-specific polymerase chain reaction (PCR), bisulfite sequencing, real-time reverse transcription-PCR and western blot analysis. The increased level of DNA methyltransferase (DNMT) 3b in 267B1/K-Ras cells was reduced by small interfering RNA-mediated knockdown of k-ras, whereas DNMT1 and DNMT3a did not change regardless of K-Ras or 5-aza-2'-deoxycytidine (5'-AzaC) treatment. Furthermore, binding of DNMT3b to E-cadherin promoter was increased in 267B1/K-Ras cells but was reduced by 5'-AzaC, as revealed by chromatin immunoprecipitation assay, which was in agreement with cell aggregation and invasive mobilization of the cells. Hence, our data suggest that increased binding of DNMT3b to E-cadherin promoter region by K-Ras cause promoter hypermethylation for reduced expression of E-cadherin, leading to the decreased cell aggregation and increased metastasis of human prostate cancer cells overexpressing K-Ras.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Azacitidine,
http://linkedlifedata.com/resource/pubmed/chemical/Cadherins,
http://linkedlifedata.com/resource/pubmed/chemical/DNA (Cytosine-5-)-Methyltransferase,
http://linkedlifedata.com/resource/pubmed/chemical/DNA methyltransferase 3B,
http://linkedlifedata.com/resource/pubmed/chemical/decitabine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
1460-2180
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1194-201
|
pubmed:meshHeading |
pubmed-meshheading:20375073-Azacitidine,
pubmed-meshheading:20375073-Cadherins,
pubmed-meshheading:20375073-Cell Communication,
pubmed-meshheading:20375073-Cell Line, Tumor,
pubmed-meshheading:20375073-Cell Movement,
pubmed-meshheading:20375073-CpG Islands,
pubmed-meshheading:20375073-DNA (Cytosine-5-)-Methyltransferase,
pubmed-meshheading:20375073-DNA Methylation,
pubmed-meshheading:20375073-Genes, ras,
pubmed-meshheading:20375073-Humans,
pubmed-meshheading:20375073-Male,
pubmed-meshheading:20375073-Promoter Regions, Genetic,
pubmed-meshheading:20375073-Prostatic Neoplasms
|
pubmed:year |
2010
|
pubmed:articleTitle |
Modulation of E-cadherin expression by K-Ras; involvement of DNA methyltransferase-3b.
|
pubmed:affiliation |
Korea Research Institute Yangcheong-Ri, Ochang, Chungbuk 363-883, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|